Login to Your Account


IDO pathway inhibitors
Newlink Genetics Corp., which has kept its head down and plowed forward in an approach reflective of its Ames, Iowa, heritage, earned validation of those efforts in a big way, inking an exclusive global license with Roche AG unit Genentech Inc. that could exceed $1 billion. more »

Opinion


Partners in Focus